乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

AHA

<乌鸦传媒>Low-Dose 'Quadpill' Reduces High Blood Pressure

Significantly lower diastolic blood pressure at 12 weeks, U.S.-based study showed

<乌鸦传媒>Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertension

Aprocitentan targets the endothelin pathway, whereas baxdrostat blocks aldosterone production

<乌鸦传媒>Can Botox for the Heart Ward Off Afib After Cardiac Surgery?

Epicardial botulinum toxin generally not better than placebo in the NOVA study

<乌鸦传媒>Precision Medicine Strategy Reduced Testing in Patients With Chest Pain

Also reduced risk of composite endpoint of death, MI, and catheterization compared with usual care

<乌鸦传媒>Anticoagulation Again Flops for Outpatient COVID-19

Largest-yet RCT shows no benefit for non-hospitalized symptomatic patients despite elevated risk

<乌鸦传媒>Upfront ECMO Disappoints for Cardiogenic Shock

High-cost procedure not yet justified as an early strategy

<乌鸦传媒>Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit

Randomized trial shows advantages across heart failure spectrum

<乌鸦传媒>Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI

BRIGHT-4 trial hands the drug a "clear, unambiguous win" against heparin

<乌鸦传媒>Early Invasive Strategy for Stable CAD Holds No Long-Term Survival Advantage

Extended follow-up of ISCHEMIA trial weighs in on mortality

<乌鸦传媒>Experts Agree Intravenous Iron Shows Promise for Heart Failure Patients

While findings were not significant, the study was impacted by COVID lockdowns, researcher says

<乌鸦传媒>Study Refutes Heart Health Claims of Dietary Supplements

LDL cholesterol reductions with cinnamon, garlic, and others not on par with statin

<乌鸦传媒>Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the ED

Pathways for HF patients picked for early discharge versus admission

<乌鸦传媒>Definitive Answer on Steroids for Infant Heart Surgery Falls Short

STRESS trial misses primary endpoint but secondary benefits are suggestive

<乌鸦传媒>Diuretics on Par in Head-to-Head Comparison for Hypertension

But a surprise signal emerges for one group in pragmatic trial

<乌鸦传媒>Mixed Results With Pemafibrate in Patients With Type 2 Diabetes

No impact on CV events in PROMINENT; developer brings trial to an end

<乌鸦传媒>Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization

Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study

<乌鸦传媒>Bentracimab on Point as Fast-Acting Ticagrelor Reversal Agent

"Immediate and sustained" benefit, interim REVERSE-IT analysis found

<乌鸦传媒>Oral Factor XIa Inhibitor Sets the Stage for a Safer Anticoagulant

Milvexian shows promise in preventing vein clots after total knee replacement surgery

<乌鸦传媒>Oral PCSK9 Inhibitor Slashed Cholesterol

Reductions of 65% observed in phase I trials

<乌鸦传媒>Potent Antiplatelet Not a Good Idea for Moderate COVID-19

ACTIV-4a trial suggests harm for hospitalized patients outside the ICU

<乌鸦传媒>Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin

EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says

<乌鸦传媒>Vascepa Succumbs as COVID Treatment in 'Underpowered' Trial

Purified fish oil didn't help SARS-CoV-2-positive outpatients

<乌鸦传媒>Aspirin Flops Again for Dementia Prevention

ASCEND trial sides with ASPREE, but can't rule out some potential benefit

<乌鸦传媒>Stem Cells Don't Prevent Acute Heart Failure Events

DREAM-HF trial does hold some positive signals, though

<乌鸦传媒>Some Good News for Curious Afib Patients Looking to Find Their Own Triggers

Presumed Afib triggers put to the test in n-of-1 studies

<乌鸦传媒>PALACS: A Win for Posterior Left Pericardiotomy for Post-Op Afib

Trial offers good news for patients getting coronary, aortic valve, and aortic surgeries

<乌鸦传媒>Two Anticoagulants -- When Used Correctly -- Similarly Protective Against Dementia

GIRAF trial tested warfarin versus dabigatran in older Afib patients

<乌鸦传媒>Coffee Causes This One Arrhythmia, Trial Shows

Overall mixed results in the CRAVE randomized trial

<乌鸦传媒>Tricuspid Repair Boosts Mitral Valve Surgery Outcomes

Randomized trial supports combined surgery for moderate regurgitation

<乌鸦传媒>Delaying Surgery Hurts Patients With Silent Aortic Stenosis

Early aortic valve replacement wins in AVATAR trial

<乌鸦传媒>Early CABG After Stopping Ticagrelor is Possible -- But is It Ready for Prime-Time?

RAPID CABG shows non-inferority of shorter wait; expert advises caution for real-world practice

<乌鸦传媒>Antibiotics Slow Down Latent Rheumatic Heart Disease in Kids

GOAL trial supports screening

<乌鸦传媒>COVID's Heart Complications Modest in Large Registry

Obese and minority groups at higher risk, though, analyses affirm

<乌鸦传媒>AHA: Highlighting Effective 'Real-World' Heart Tx Strategies

Studies on overcoming GDMT underuse, improving self-care education, creating new settings for care delivery

<乌鸦传媒>Post-Surgery Monitoring Finds Afib in Discharged Patients

About 20% of patients had episodes recorded on devices, study showed

<乌鸦传媒>Sotagliflozin Prevents Heart Events in Acute HF, Chronic Kidney Disease

Two trials show some tantalizing signals for HFpEF and stroke

<乌鸦传媒>Novel Screening Approach Promising for Silent CAD

More than 40% of healthy Swedish participants still had subclinical coronary artery disease

<乌鸦传媒>VITAL-AF, mSToPS: Mixed Results in Afib Screening

A signal that screening by continuous ECG monitoring leads to better outcomes

<乌鸦传媒>Skip Rhythm Drugs, Go Straight to Cryoablation for Afib

Two trials support shift into first-line strategy

<乌鸦传媒>ANGPTL3 Blocker Halves LDL in High-Risk Group

Evinacumab worked in patients refractory to statins, PCSK9 inhibitors

1